🟢 Tenaya Therapeutics is trading 5% up today with no confirmed catalyst

Tenaya Therapeutics is trading 5.13% higher at $0.62 now, with no company-specific reason identified for the session’s move.

• No company-specific announcement dated September 30, 2026, was identified; the latest company news found was the September 3 FDA RMAT designation for TN-401.
• August inflation came in below expectations, and the Nasdaq was up 0.72% at 9:55 a.m. ET. This backdrop may be supportive, but a causal link is unconfirmed.